Use of the expanded Apgar score for the assessment of intraventricular and intraparenchymal haemorrhage risk in neonates

被引:0
|
作者
Goralska, Agnieszka [1 ]
Puskarz-Gasowska, Joanna E. [1 ]
Bujnowski, Pawel [2 ]
Bokiniec, Renata [1 ]
机构
[1] Med Univ Warsaw, Neonatal & Intens Care Dept, Karowa 2, PL-00315 Warsaw, Poland
[2] Polish Acad Sci, Syst Res Inst, Warsaw, Poland
关键词
algorithm; Apgar score; CHIAD; IPH; IVH; TERM NEWBORNS; ASPHYXIA; RESUSCITATION; INFANTS;
D O I
10.5603/GP.a2022.0046
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Preterm birth is a key factor contributing to haemorrhage incidence in neonates. This study focused on defining relevant parameters for the assessment of intraventricular and intraparenchymal haemorrhage risks in neonates. Material and methods: Chi-square automatic interaction detection was used to analyse the Apgar score (AS), the Apgar max score, and the course of resuscitation documented according to the expanded AS in 696 infants born between 2009 and 2011 in the Neonatal and Intensive Care Department of the Medical University of Warsaw. Results: Gestational age was the most relevant discriminating variable for the prediction of intraventricular III degree and intraparenchymal haemorrhage incidences. Infants born before the 31st week of pregnancy made up 80% of the intraventricular or intraparenchymal haemorrhage cases. Additionally, a fraction of inspired oxygen > 0.8 at ten minutes after birth was a better discriminating variable in the youngest neonates than an Apgar max score <= 5, identifying 31.6% and 20.6% of infants with intraventricular and intraparenchymal haemorrhage, respectively. Conclusions: Consideration of the oxygen concentration supplied during resuscitation significantly improves the prognosis of intraventricular and intraparenchymal haemorrhages in preemies compared to the use of the classical AS.
引用
收藏
页码:146 / 151
页数:6
相关论文
共 50 条
  • [31] THE USE OF EXPANDED RISK SCORE IN RA (ERS-RA) FOR THE DEFINITION OF RISK FOR MAJOR CARDIOVASCULAR EVENTS IN PATIENTS CANDIDATES TO RECEIVE JANUS KINASES INHIBITORS
    Favalli, E. G.
    Cincinelli, G.
    Orsini, F.
    Manara, M.
    Germinario, S.
    Biggioggero, M.
    Di Taranto, R.
    Ferrito, M.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 851 - 852
  • [32] A report of the use of the Dynamic Objective Risk Assessment (DORA) score in the changing pediatric intensive care environment
    Heard, CMB
    Fletcher, JE
    Papo, MC
    CRITICAL CARE MEDICINE, 1998, 26 (09) : 1593 - 1595
  • [33] Use of Framingham Risk Score as a Clinical Tool for the Assessment of Fitness for Work: Results From a Cohort Study
    Palladino, Raffaele
    Caporale, Oreste
    Nardone, Antonio
    Fiorentino, Denise
    Torre, Ida
    Triassi, Maria
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2016, 58 (08) : 805 - 809
  • [34] How nurses use National Early Warning Score and Individual Early Warning Score to support their patient risk assessment practice: A fieldwork study
    Langkjaer, Caroline S.
    Bundgaard, Karin
    Bunkenborg, Gitte
    Nielsen, Pernille B.
    Iversen, Kasper K.
    Bestle, Morten H.
    Bove, Dorthe G.
    JOURNAL OF ADVANCED NURSING, 2023, 79 (02) : 789 - 797
  • [35] The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events
    Favalli, Ennio Giulio
    Cincinelli, Gilberto
    Germinario, Sabino
    Di Taranto, Raffaele
    Orsini, Francesco
    Maioli, Gabriella
    Biggioggero, Martina
    Ferrito, Matteo
    Caporali, Roberto
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [36] Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study
    Shin, Ju-Young
    Park, Mi-Ju
    Lee, Shin Haeng
    Choi, So-Hyun
    Kim, Mi-Hee
    Choi, Nam-Kyong
    Lee, Joongyub
    Park, Byung-Joo
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [37] Clinical Use of a Proteomic Cardiovascular Risk Score for Assessing How Personal Risk Assessment Positively Drives Patient Attitudes and Behavior Change
    Trujillo, Nelson P., Jr.
    Wall, Kirsten
    Alexander, Leigh
    Housholder, Sandy
    Zach, Jordan
    Gill, Rosalyn
    Williams, Stephen
    CIRCULATION, 2019, 139
  • [38] A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score
    Allman, Richard
    Spaeth, Erika
    Lai, John
    Gross, Susan J.
    Hopper, John L.
    PLOS ONE, 2021, 16 (01):
  • [39] Classification and Assessment of Medication Risk in the Elderly (CARE): Use of a Medication Risk Score to Inform Patients' Readmission Likelihood after Hospital Discharge
    SanFilippo, Savanna
    Michaud, Veronique
    Wei, Juanqin
    Bikmetov, Ravil
    Turgeon, Jacques
    Brunetti, Luigi
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [40] Combined use of the GRACE ACS risk score and comorbidity indices to increase the effectiveness of hospital mortality risk assessment in patients with acute coronary syndrome
    Zykov, Mikhail, V
    Dyachenko, Nikita, V
    Velieva, Rufana M.
    Kashtalap, Vasily V.
    Barbarash, Olga L.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (07): : 816 - 821